TG THERAPEUTICS, INC. Public Float
TG THERAPEUTICS, INC. (TGTX) had Public Float of $2.50 billion as of 2025-06-30, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-27
- 2025-06-30: Entity Public Float $2.50B.
- 2024-06-30: Entity Public Float $2.50B.
- 2023-06-30: Entity Public Float $3.40B.
- 2022-06-30: Entity Public Float $564.45M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $2.50B 10-K · filed 2026-02-27 |
| 2024-06-30 | $2.50B 10-K · filed 2025-03-03 |
| 2023-06-30 | $3.40B 10-K/A · filed 2024-08-09 |
| 2022-06-30 | $564.45M 10-K · filed 2023-03-01 |
| 2021-06-30 | $4.94B 10-K · filed 2022-03-01 |
| 2020-06-30 | $2.16B 10-K · filed 2021-03-01 |
| 2019-06-30 | $687.57M 10-K · filed 2020-03-02 |
| 2018-06-30 | $917.40M 10-K · filed 2019-03-01 |
| 2017-06-30 | $490.25M 10-K · filed 2018-03-15 |
| 2016-06-30 | $221.00M 10-K · filed 2017-03-16 |
| 2015-06-30 | $570.13M 10-K · filed 2016-03-15 |
| 2014-06-30 | $207.00M 10-K · filed 2015-03-16 |
| 2013-06-30 | $74.98M 10-K · filed 2014-03-07 |
| 2012-06-30 | $69.29M 10-K · filed 2013-03-21 |
| 2011-06-30 | $619.42K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |